HBsAG Hepatitis B Screening Test (NHC Offer)

The HBsAg Hepatitis B Screening Test (NHC Offer) is a blood test used to detect the presence of Hepatitis B Surface Antigen (HBsAg), a protein found on the surface of the Hepatitis B virus (HBV). The presence of HBsAg in the blood indicates an active Hepatitis B infection, which may be either acute or chronic. This test is commonly used as the primary screening tool for identifying Hepatitis B infection and assessing the risk of transmitting the virus to others.

The HBsAg Screening Test is recommended for individuals at risk of Hepatitis B infection, including blood donors, pregnant women, healthcare workers, people with liver disease, and individuals with possible exposure to infected blood or body fluids. It is also used to investigate symptoms such as jaundice, fatigue, loss of appetite, nausea, abdominal pain, and dark-colored urine. No fasting is required before the test. A negative result generally indicates that no Hepatitis B surface antigen was detected, while a positive result suggests an active Hepatitis B infection and may require additional tests such as HBV DNA, HBeAg, Anti-HBs, and liver function tests for confirmation and disease evaluation. Early detection through HBsAg screening supports timely treatment, reduces the risk of liver complications, and helps prevent the spread of Hepatitis B.